| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025263 |
| Receipt No. | R000029059 |
| Official scientific title of the study | A verification study on swelling reduction effect by plant-derived ingredients containing food |
| Date of disclosure of the study information | 2018/02/28 |
| Last modified on | 2017/05/02 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | A verification study on swelling reduction effect by plant-derived ingredients containing food | |
| Title of the study (Brief title) | A verification study on swelling reduction effect by plant-derived ingredients containing food | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To verify the effects on the facial swelling after drinking alcohol by test food |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 1.Subjective symptoms for swelling: questionnaire |
| Key secondary outcomes | 1. Leg swelling
Water tank volume immersion and calf circumference 2. Facial swelling High resolution analyzed image, moisture, oiliness, skin tone, pigmentation (the number of pigmentations and total area of pigmentations), pores, wrinkle (the number of wrinkles and total length and areas), texture 3. Subjective symptoms related to swelling of health: questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1. Single-dose study
Test materials: 50 mg of plant-derived ingredients containing tablets Duration: 1 day Administration: After two hours at intake 8 tablets of the test food, measure swelling *Drink 350 mL of beer with alcohol content of 5% at night before the examination day 2. Continuation-dose study Test materials: 50 mg of plant-derived ingredients containing tablet Duration: 1 week Administration: Take 8 tablets of the test food per day any time during the day *Drink 350 mL of beer with alcohol content of 5% at night before the examination day |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Healthy adults Japanese women
2. Those who received a full explanation of the procedures in the study, and informed consent was documented and signed by all of the participants |
|||
| Key exclusion criteria | 1. To diagnose kidney function works abnormity (urine proteins, creatinine etc. as biomarker) by urinalysis
2. Diastolic pressure is more than 135 mmHg 3. Those who are allergic to citrus fruits 4. Those who are pregnant, breast-feeding, or are expected to become pregnant during the test period 5. Those who had and plan to have surgery and/or hospitalization within 2 months before and after the study period of Nov. 2016 to May 2017 6. Others consider as inappropriate for this test by the physician |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiko YOSHIKAWA |
| Organization | SAPPORO HOLDINGS LTD. |
| Division name | Group Research and Development Division |
| Address | 4-20-1 Ebisu, Shibuya-ku, Tokyo. |
| TEL | 03-5795-1201 |
| Kazuhiko.yoshikawa@pokkasapporo-fb.co.jp | |
| Public contact | |
| Name of contact person | Kazuhiko YOSHIKAWA |
| Organization | SAPPORO HOLDINGS LTD. |
| Division name | Group Research and Development Division |
| Address | 4-20-1 Ebisu, Shibuya-ku, Tokyo. |
| TEL | 03-5795-1201 |
| Homepage URL | |
| Kazuhiko.yoshikawa@pokkasapporo-fb.co.jp | |
| Sponsor | |
| Institute | SAPPORO HOLDINGS LTD. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | サッポロホールディングス株式会社本社(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029059 |